Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News
May 05, 2011
Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News
Quest gains CE Mark for Simplexa C. difficile test
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- PCR Probe Licensing Pact with Focus Diagnostics Portends 'Busy Year' for Evogen
March 14, 2013 / PCR Insider - Dx Focus: Quest Simplexa C. Diff Assay Gets FDA OK; XDx Begins AlloMap Testing in Germany
April 12, 2012 / PCR Insider - Dx Focus: OraSure Gets FDA OK for DNA Collection Device; Quest Dengue Test Approved in Brazil
December 8, 2011 / PCR Insider - Quest's Focus Diagnostics Launches Nucleic Acid Extraction-Free Flu/RSV Test in Europe
November 3, 2011 / PCR Insider - Meridian Bioscience Q1 Revs Drop 12 Percent
January 20, 2011 / GenomeWeb Daily News